Flagship Harbor Advisors LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Flagship Harbor Advisors LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 8.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 6,091 shares of the healthcare conglomerate’s stock after purchasing an additional 451 shares during the quarter. Flagship Harbor Advisors LLC’s holdings in UnitedHealth Group were worth $3,128,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Atticus Wealth Management LLC grew its stake in shares of UnitedHealth Group by 53.8% in the 2nd quarter. Atticus Wealth Management LLC now owns 612 shares of the healthcare conglomerate’s stock valued at $314,000 after purchasing an additional 214 shares during the last quarter. IMS Capital Management grew its stake in shares of UnitedHealth Group by 1.2% in the 2nd quarter. IMS Capital Management now owns 2,759 shares of the healthcare conglomerate’s stock valued at $1,417,000 after purchasing an additional 32 shares during the last quarter. Private Advisor Group LLC lifted its holdings in shares of UnitedHealth Group by 2.8% in the 2nd quarter. Private Advisor Group LLC now owns 92,882 shares of the healthcare conglomerate’s stock valued at $47,707,000 after buying an additional 2,528 shares during the period. Gateway Investment Advisers LLC lifted its holdings in shares of UnitedHealth Group by 2.4% in the 2nd quarter. Gateway Investment Advisers LLC now owns 301,454 shares of the healthcare conglomerate’s stock valued at $154,836,000 after buying an additional 7,005 shares during the period. Finally, PFG Advisors lifted its holdings in shares of UnitedHealth Group by 3.0% in the 2nd quarter. PFG Advisors now owns 7,559 shares of the healthcare conglomerate’s stock valued at $3,882,000 after buying an additional 222 shares during the period. 87.25% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $517.46 on Friday. The business has a fifty day simple moving average of $530.11 and a 200-day simple moving average of $512.45. UnitedHealth Group Incorporated has a 52 week low of $383.12 and a 52 week high of $553.29. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The company has a market cap of $484.02 billion, a P/E ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm had revenue of $80.33 billion during the quarter, compared to the consensus estimate of $79.68 billion. During the same quarter in the previous year, the business earned $4.70 earnings per share. The firm’s quarterly revenue was up 12.6% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were given a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date of this dividend was Friday, September 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.46%.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other UnitedHealth Group news, CEO Dirk C. Mcmahon sold 14,715 shares of the business’s stock in a transaction dated Thursday, August 18th. The stock was sold at an average price of $543.32, for a total transaction of $7,994,953.80. Following the transaction, the chief executive officer now owns 50,108 shares in the company, valued at $27,224,678.56. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The disclosure for this sale can be found here. Insiders have sold a total of 139,051 shares of company stock worth $74,450,958 over the last quarter. 0.40% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have recently commented on UNH shares. SVB Leerink raised their price target on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a report on Thursday, September 8th. Mizuho lifted their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, August 10th. UBS Group lifted their price objective on UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a report on Thursday, July 21st. Finally, BMO Capital Markets boosted their price target on UnitedHealth Group from $600.00 to $610.00 in a report on Wednesday, July 20th. Three equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $586.40.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.